Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients (Q44627507)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 1, 2003
edit
Language Label Description Also known as
English
Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients
scientific article published on January 1, 2003

    Statements

    Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients (English)
    Isabelle Lemieux
    Hervé Salomon
    1 January 2003
    442-448

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit